Emerging Trends to Reshape the Structural Heart Devices Market: Advancements In Minimally Invasive Repair Devices For Structural Heart Conditions as a Key Influencer

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Structural Heart Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, there has been a substantial growth in the structural heart devices market. It is expected to expand from $10.41 billion in the year 2024 to about $11.44 billion by 2025, marking a compound annual growth rate (CAGR) of 9.9%. The significant growth observed in the past can be credited to the shift towards less invasive surgical methods, the increased demand for minimally invasive structural heart devices, ongoing education and training programs for healthcare professionals, an increase in healthcare spending, along with a rising preference among patients for non-surgical or minimally invasive treatment alternatives.

Structural Heart Devices Market Size Forecast: What's the Projected Valuation by 2029?
Expectations indicate that the structural heart devices market will witness robust expansion in the forthcoming years, with projections estimating its worth to reach $16.48 billion by 2029, growing at a compounded annual growth rate (CAGR) of 9.6%. This anticipated growth during the forecast period can be credited to factors such as the rising elderly population, heightened awareness concerning cardiac health, initiation of screening programs, favorable compensation strategies for structural heart operations, and timely consent from regulatory bodies for fresh structural heart devices. Key trends anticipated during the forecast timeline encapsulate the escalating adoption of transcatheter valve replacements, sustained invention of devices armed with advanced materials, a rising focus on individualized treatment plans, an uptick in the adoption of hybrid procedures, alongside the integration of remote surveillance and telehealth resolutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

What Are the Drivers Transforming the Structural Heart Devices Market?
The increasing incidence of cardiovascular diseases is anticipated to boost the expansion of the structural heart device market. Cardiovascular diseases (CVDs), encompassing disorders that affect the heart and blood vessels like coronary artery disease, heart attacks, and strokes, have been progressively escalating worldwide due to inactive lifestyles, unhealthy eating habits, a surge in obesity rates, smoking, and aging populations. Structural heart devices, used to mend or replace faulty heart valves and correct structural flaws, enhance heart performance and patient results. As per the statistics presented by the British Heart Foundation, a cardiovascular research charity based in the UK, around 7.6 million people are impacted by heart and circulatory diseases in the UK in September 2024, comprising nearly 4 million males and 3.6 million females. These conditions account for approximately 27% of all deaths in the UK, equal to over 170,000 deaths annually, or around 480 deaths daily, amounting to one death every three minutes. Hence, the escalating incidence of cardiovascular diseases is fuelling the expansion of the structural heart device market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15677&type=smp

What Long-Term Trends Will Define the Future of the Structural Heart Devices Market?
Key players in the structural heart devices market are focusing on inventing procedures and tools for minimally invasive treatments. These advancements aim to improve patient prognosis, lower recovery duration, and broaden the range of treatments for structural heart disorders. One such device, the self-expanding transcatheter aortic valve implantation (TAVI) system, is engineered to deploy and fix the replacement valve in the aortic valve's natural structure without the need for balloon inflation. An example of this was seen in December 2022 when Abbott Laboratories, an American company revolving around medical device and healthcare product manufacturing, rolled out its latest TAVI system, Navitor, in India. Tailored for patients with severe aortic stenosis at a high or extreme surgical risk, Navitor contains unique design elements aimed at preventing valve leakage. It effectively augments Abbott's suite of structural heart transcatheter devices, supplying doctors and patients with less invasive treatment alternatives for cardiovascular conditions. Navitor is also notable as the only self-expanding TAVI system that boasts intra-annular leaflets and large frame cells, which eases access to coronary arteries for possible future CAD interventions. Additionally, this innovative design also bolsters hemodynamics, thus enhancing blood flow.

Which Segments in the Structural Heart Devices Market Offer the Most Profit Potential?
The structural heart devices market covered in this report is segmented -

1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems
2) By Procedure: Replacement Procedures, Repair Procedures
3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications
4) By Age Group: Pediatric, Adults

Subsegments:
1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings
2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings
3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders
4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15677&type=smp

Which Firms Dominate the Structural Heart Devices Market by Market Share and Revenue in 2025?
Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Bracco Group, LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, TTK Healthcare Limited, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH, Navilyst Medical Inc.

Which Regions Offer the Highest Growth Potential in the Structural Heart Devices Market?
North America was the largest region in the structural heart devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15677

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.